Related Experiment Video
Updated: Aug 30, 2026

Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids
Published on: October 21, 2022
Activation of Fas receptor modulates cytochrome P450 3A4 expression in human colon carcinoma cells
Young-Jin Chun1, Sungsik Park, Soon Ae Yang
1College of Pharmacy, Chung-Ang University, 221 Huksuk-Dong, Dongjak-Ku, Seoul 156-756, South Korea. yjchun@cau.ac.kr
Abstract:
The Fas (CD95, APO-1) receptor is a transmembrane cell surface receptor that mediates apoptosis in many cell types when bound by the Fas ligand or cross-linked by agonistic anti-Fas antibodies. Fas activation engages a potent and rapid signaling mechanism in a variety of cell types. In the present study, we have investigated the effects of Fas receptor activation on CYP3A4 expression in human colon carcinoma HT-29 cells. The intracellular ceramide levels were significantly enhanced by the treatment with the anti-Fas antibodies and both CYP3A4 protein and mRNA expression was suppressed by Fas activation in a dose-dependent manner. Immunoblot analyses showed that the expression of iNOS protein was significantly stimulated by an anti-Fas antibody treatment in HT-29 cells. Fas receptor activation also increased the generation of reactive oxygen species, and N-acetylcysteine, a well-known antioxidant, could block Fas-mediated iNOS induction. These results show that the Fas receptor-mediated signaling pathways modulate CYP3A4 expression in human colon cancer cells. Overall, iNOS induction and P450 3A4 suppression by Fas activation may cause toxic cellular damage in gastrointestinal tissues.
Insights
Fas receptor activation suppresses CYP3A4 expression and induces iNOS in colon cancer cells. This Fas signaling pathway modulation may lead to cellular damage in gastrointestinal tissues.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Fas receptor (CD95, APO-1) is a cell surface receptor mediating apoptosis.
- Fas activation triggers rapid intracellular signaling pathways.
- CYP3A4 is a crucial enzyme in drug metabolism and detoxification.
Purpose of the Study:
- To investigate the impact of Fas receptor activation on CYP3A4 expression in human colon carcinoma HT-29 cells.
- To explore the role of Fas signaling in regulating iNOS expression and reactive oxygen species generation.
Main Methods:
- Treatment of HT-29 cells with agonistic anti-Fas antibodies.
- Measurement of intracellular ceramide levels.
- Immunoblot analysis for CYP3A4 and iNOS protein expression.
- Assessment of mRNA expression for CYP3A4.
- Detection of reactive oxygen species generation.
- Evaluation of N-acetylcysteine's effect on iNOS induction.
Main Results:
- Fas activation significantly enhanced intracellular ceramide levels.
- Fas activation dose-dependently suppressed both CYP3A4 protein and mRNA expression.
- Anti-Fas antibody treatment significantly stimulated iNOS protein expression.
- Fas receptor activation increased reactive oxygen species generation.
- N-acetylcysteine blocked Fas-mediated iNOS induction.
Conclusions:
- Fas receptor-mediated signaling pathways modulate CYP3A4 expression in human colon cancer cells.
- Fas activation leads to iNOS induction and CYP3A4 suppression.
- These combined effects may contribute to toxic cellular damage in gastrointestinal tissues.
More Related Videos
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
The Extrinsic Apoptotic Pathway

